Mehrdad Rezaee MD
Adult Congenital Heart Disease, Interventional Cardiology
Physician
Join to View Full Profile
2030 Forest AveSuite 210San Jose, CA 95128
Phone+1 408-295-2257
Fax+1 408-295-2264
Are you Dr. Rezaee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mehrdad Rezaee, MD is a cardiologist in San Jose, California. He is currently licensed to practice medicine in California.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1997 - 2000
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1994 - 1997
Medical College of WisconsinClass of 1994- Medical College of WisconsinClass of 1994
Certifications & Licensure
CA State Medical License 1997 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 8 citationsDevelopment and validation of risk prediction models for multiple cardiovascular diseases and Type 2 diabetesMehrdad Rezaee, Igor Putrenko, Arsia Takeh, Andrea Ganna, Erik Ingelsson
Plos One. 2020-07-29 - Arteriotomy closure device application following percutaneous coronary intervention may prevent bleeding complications in patients with acute myocardial infarction.Fumiaki Ikeno, M. Ali Sadoughi, Jennifer Lyons, Farshad Raissi Shabari, Kourosh Pourdehmobed
International Journal of Cardiology. 2007-04-12 - 45 citationsImpaired perfusion after myocardial infarction is due to reperfusion- induced δPKC-mediated myocardial damageFumiaki Ikeno, Koichi Inagaki, Mehrdad Rezaee, Daria Mochly-Rosen
Cardiovascular Research. 2007-03-01
Press Mentions
Cocoa Shown to Lower Blood Pressure, May Offer Treatment for HypertensionAugust 2nd, 2022- Office of Communications and Public AffairsNovember 8th, 2021
- Mynomx Announces Scientific Validation of Its Cardiometabolic Risk Engines for Assessing Risk of COVID-19 in PopulationsJune 5th, 2020
- Join now to see all
